French startup Bioptimus, which aims to create an AI foundation model for research and innovation for biology, announced its launch with $35 million in seed funding.
Sofinnova Partners led the round with support from Bpifrance Large Venture and Frst and multistage VC Cathay Innovation.
Hummingbird, Headline, Okin, NJF Capital, TopHarvest Capital, and tech entrepreneur Xavier Neal also participated in the round.
what does it do.
Biooptimus is building an AI foundation model integrating biology (from molecules to cells, tissues and whole organisms) with creative AI to drive scientific breakthroughs and innovations in biomedicine.
Former scientist from Google DeepMind and French artificial intelligence company Okon founded the Paris-based company.
It will utilize Okin’s data generation capabilities, access to multimodal patient data from academic hospitals worldwide, and a computing environment. Amazon Web Services.
“Foundation models in biology and the application of creative AI are poised to have a profound impact on science,” said Dr. Jean-Philippe Wert, co-founder and CEO of Biooptimus, chief research and development officer at Okon and former research lead at Google Brain. said in a statement.
“Using the power of foundational models and advanced algorithms trained on large scales of biological and multimodal data, we aim to capture the laws of biology that have so far been too complex to accurately interpret. Be understood. Be critical to accelerating biomedical and environmental science.”
Market Snapshot
GenAI is increasingly being used The life sciences sector by companies like Absci, a startup focused on developing generative AI antibody discovery technology. German pharmaceutical company Boehringer Ingelheim and tech company IBM; California-based AI drug discovery startup Genesis; and AI-powered biotech company Vivodyne in Philadelphia.
Living in Israel AION Labs, an AI-powered drug discovery partnership between global pharma and tech companies, has also announced the launch of several of its AI-powered drug discoveries, including DenovAI and TenAces.
“Improving Immunization Data Quality Through EHR and Public Health Collaboration” is scheduled for Tuesday, March 12, 1:30-2:30 pm ET in Room W311E at HIMSS24 in Orlando. Learn more and register.